# A Comparison of VR647 and Conventionally Nebulized Budesonide in Healthy Volunteers and Adult Asthma Subjects

> **NCT04032834** · PHASE1 · COMPLETED · sponsor: **Vectura Limited** · enrollment: 34 (actual)

## Conditions studied

- Asthma

## Interventions

- **COMBINATION_PRODUCT:** VR647 Inhalation Suspension (budesonide) 1 mg/2 mL delivered by the VR647 Inhalation System (AKITA JET) with mouthpiece
- **COMBINATION_PRODUCT:** VR647 Inhalation Suspension (budesonide) 1 mg/2 mL delivered by the VR647 Inhalation System (AKITA JET) with facemask
- **COMBINATION_PRODUCT:** 1 mg/2 mL Pulmicort Respules delivered by a conventional jet nebulizer (PARI VIOS) with mouthpiece
- **COMBINATION_PRODUCT:** 1 mg/2 mL Pulmicort Respules delivered by a conventional jet nebulizer (PARI VIOS) with facemask
- **COMBINATION_PRODUCT:** 0.5 mg/2 mL Pulmicort Respules delivered by a conventional jet nebulizer (PARI VIOS) with mouthpiece
- **COMBINATION_PRODUCT:** 0.5 mg/2 mL Pulmicort Respules delivered by a conventional jet nebulizer (PARI VIOS) with facemask

## Key facts

- **NCT ID:** NCT04032834
- **Lead sponsor:** Vectura Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-20
- **Primary completion:** 2017-05-22
- **Final completion:** 2017-05-22
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2019-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04032834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04032834, "A Comparison of VR647 and Conventionally Nebulized Budesonide in Healthy Volunteers and Adult Asthma Subjects". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT04032834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*